Vivani Medical
VANI
39 hedge funds and large institutions have $9.08M invested in Vivani Medical in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 16 closing their positions.
1.02% less ownership
Funds ownership: 3.41% → 2.39% (-1%)
13% less funds holding
Funds holding: 45 → 39 (-6)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
45% less call options, than puts
Call options by funds: $859K | Put options by funds: $1.57M
53% less capital invested
Capital invested by funds: $19.2M → $9.08M (-$10.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$550K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$439K |
| 3 |
Jane Street
New York
|
+$263K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$256K |
| 5 |
VF
Virtu Financial
New York
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$1.85M |
| 2 |
BlackRock
New York
|
-$1.46M |
| 3 |
NAM
NewGen Asset Management
Toronto,
Ontario, Canada
|
-$988K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$863K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$750K |
VANI Hedge Fund Activity: Q3 2021 in Review
39 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2021, worth a combined $9.08M — down 53% from $19.2M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of VANI and 10 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Morgan Stanley, adding an estimated $550K. The largest seller was Altium Capital Management, exiting entirely with an estimated $1.85M sold.
- 39 institutional investors held Vivani Medical (VANI) as of Q3 2021, down from 45 in Q2 2021.
- Funds reported $9.08M of Vivani Medical stock for Q3 2021, down 53% quarter-over-quarter.
- 10 funds opened new Vivani Medical positions in Q3 2021 and 16 closed out, a net change of -6 holders.
- The largest Vivani Medical buyer in Q3 2021 was Morgan Stanley, an estimated $550K added.
- The largest Vivani Medical seller in Q3 2021 was Altium Capital Management, an estimated $1.85M sold.
Based on aggregated 13F filings for Q3 2021.